Haemonetics Corp. engages in the development and distribution of hematology products and solutions. The company is headquartered in Boston, Massachusetts and currently employs 3,023 full-time employees. Its solutions address critical medical needs, which includes a suite of hospital technologies designed to advance standards of care and help enhance outcomes for patients; end-to-end plasma collection technologies to optimize operations for plasma centers, and products to enable blood centers to collect in-demand blood components. Its Plasma segment includes plasma collection devices and disposables, donor management software and supporting software solutions. Its Blood Center segment manufactures and provides customers with its full line of apheresis solutions for automated blood collection. Its Hospital segment consists of Interventional Technologies, which includes Vascular Closure, Sensor Guided Technologies and Esophageal Protection products, and Blood Management Technologies (Hemostasis Management, Cell Salvage and Transfusion Management products). The company also offers solutions for structural heart and endovascular procedures.
Mr. Christopher Simon 2016 'den beri şirketle birlikte olan Haemonetics Corp 'in President 'ıdır.
HAE hissesinin fiyat performansı nasıl?
HAE 'in mevcut fiyatı $58.46 'dir, son işlem günde 0% azalmış etti.
Haemonetics Corp için ana iş temaları veya sektörler nelerdir?
Haemonetics Corp Health Care endüstrisine ait ve sektör Health Care 'dir
Haemonetics Corp 'in piyasa değerlemesi nedir?
Haemonetics Corp 'in mevcut piyasa değerlemesi $2.7B 'dir
Haemonetics Corp al, sat, yoksa beklemeli mi?
Wall Street analistlerine göre, 11 analist Haemonetics Corp için analist derecelendirmeleri gerçekleştirdi, bunlar 5 güçlü al, 7 al, 2 tut, 1 sat ve 5 güçlü sat içermektedir